Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M Ludden

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Journal of Pharmaceutical Sciences|July 1, 1984
Plasma protein binding of warfarin: methodological considerationsD Mungall, Y Y Wong, R L Talbert, et al.
Journal of Pharmaceutical Sciences|September 1, 1988
Absolute bioavailability and dose proportionality of betaxolol in normal healthy subjectsT M Ludden, D A Boyle, D Gieseker, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
A phase I and pharmacokinetic comparison of hepatic arterial and peripheral vein infusions of bisantrene for liver cancerG R Weiss, M Hersh, J G Kuhn, et al.
Journal of Medicine|January 1, 1993
Serum levels of pentoxifylline and its metabolites in non-tumor-bearing mice after chronic oral pentoxifylline administrationF E Johnson, K C Tolman, S A Farr, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1989
Disposition of the radioprotector ethiofos in the rhesus monkey. Influence of route of administrationD J Mangold, M A Miller, B K Huelle, et al.
Clinical Pharmacy|November 1, 1987
Disposition of phenytoin in critically ill trauma patientsB A Boucher, J H Rodman, T C Fabian, et al.
Journal of Cardiovascular Pharmacology|October 1, 1990
Effect of food on oral availability of apresoline and controlled release hydralazine in hypertensive patientsS H Jackson, A M Shepherd, T M Ludden, et al.
Journal of Pharmaceutical Sciences|March 1, 1978
Microdetermination of procainamide in human serumT M Ludden, D Lalka, M G Wyman, et al.
Research Communications in Chemical Pathology and Pharmacology|September 1, 1975
Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexolL Malspeis, M S Bathala, T M Ludden, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Pharmacokinetics of ametantrone acetate (NSC-287513)J G Kuhn, C E Balmer, T M Ludden, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Journal of Pharmaceutical Sciences|July 1, 1984
Plasma protein binding of warfarin: methodological considerationsD Mungall, Y Y Wong, R L Talbert, et al.
Journal of Pharmaceutical Sciences|September 1, 1988
Absolute bioavailability and dose proportionality of betaxolol in normal healthy subjectsT M Ludden, D A Boyle, D Gieseker, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
A phase I and pharmacokinetic comparison of hepatic arterial and peripheral vein infusions of bisantrene for liver cancerG R Weiss, M Hersh, J G Kuhn, et al.
Journal of Medicine|January 1, 1993
Serum levels of pentoxifylline and its metabolites in non-tumor-bearing mice after chronic oral pentoxifylline administrationF E Johnson, K C Tolman, S A Farr, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1989
Disposition of the radioprotector ethiofos in the rhesus monkey. Influence of route of administrationD J Mangold, M A Miller, B K Huelle, et al.
Clinical Pharmacy|November 1, 1987
Disposition of phenytoin in critically ill trauma patientsB A Boucher, J H Rodman, T C Fabian, et al.
Journal of Cardiovascular Pharmacology|October 1, 1990
Effect of food on oral availability of apresoline and controlled release hydralazine in hypertensive patientsS H Jackson, A M Shepherd, T M Ludden, et al.
Journal of Pharmaceutical Sciences|March 1, 1978
Microdetermination of procainamide in human serumT M Ludden, D Lalka, M G Wyman, et al.
Research Communications in Chemical Pathology and Pharmacology|September 1, 1975
Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexolL Malspeis, M S Bathala, T M Ludden, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Pharmacokinetics of ametantrone acetate (NSC-287513)J G Kuhn, C E Balmer, T M Ludden, et al.
Pageof 13